Apollo Applied Research is the Leading Medical Cannabis Research Clinic in Canada.
Patient-Focused Clinical Studies
Apollo’s participation in medical cannabis research is what puts us in a category all our own. Our process was designed with the help of scientists, doctors, and PhDs. We currently have 7 full time researchers on staff and 10 doctors who review our findings and actively support our studies.
Continuing research helps better evaluate the benefits of medical marijuana and allows us to discover the best strains and treatment plans for each condition and each patient.
Cannabis and Driving
Apollo Applied Research is conducting a government-funded study in collaboration with the University Health Network to evaluate cannabis-induced impairments in driving performance.
Apollo Applied Research is focused on gathering information to determine the most effective, reliable and high quality medical cannabis for patients with chronic pain.
Veterans With PTSD
Veterans and military personnel are common medical marijuana candidates due to the increased risk of Post Traumatic Stress Disorder. Medical cannabis, along with counselling and medication are all viable and effective means of treating PTSD
The goal of our research is to analyze the positive effect of medical cannabis on the quality of life of Canadian chronic pain sufferers. We want to understand how medical cannabis can be used effectively to treat your chronic pain and symptoms, while minimizing the undesirable side effects.
Clinical Cannabis Research
The top Canadian pain specialists have assisted our cannabis research, allowing us to cultivate the best knowledge surrounding medical marijuana available. Apollo’s medical research team is currently seeking patients to help shape the future of Health Canada-approved medical cannabis. If you would like to be a part of the solution, we’d like to hear from you!
Help Us Help You Control Your Pain.
Apollo’s Preliminary Findings:
Data taken from our own studies with Apollo patients support positive findings for the use of medical marijuana. Of those participating, 27% stated a lowered use of opioid medication, while more than 30% claimed a reduction in pain score.
To find out more, contact the Apollo Research Team at firstname.lastname@example.org